DBV Technologies | DBVT - Текущие активы





Текущие активы Изменить Дата
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amarin USD 626.02M 23.87M 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
DBV Technologies USD 246.7M 33.76M 2026-03
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Galectin Therapeutics USD 27.29M 1.83M 2024-06
Halozyme Therapeutics USD 1B 177.83M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03